Drug-Related Side Effects and Adverse Reactions Clinical Trial
Official title:
An Open Label Positron Emission Tomography (PET) Imaging Study Using 89Zirconium Labeled GSK3128349 to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 Following Single Dose Intravenous Administration in Healthy Male Subjects
GSK3128349 is a small protein molecule (biopharmaceutical) that binds to albumin in the body, and by itself, has no pharmacological action. A pharmacologically active drug can be attached to GSK3128349 with the goal of changing the distribution and/or duration of action of the attached drug. This study will determine the distribution and pharmacokinetics (duration) of GSK3128349 itself after a single intravenous infusion. GSK3128349 has been labeled with and the radioisotope 89Zirconium allowing it to be visualized in the organs of the body using a PET scanner at multiple time points after GSK3128349 dosing. The data from this study will help predict the distribution of future drugs attached to GSK3128349. The total duration of a subject's participation is about approximately 10 weeks, including the screening period.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03258151 -
Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
|
||
| Recruiting |
NCT05202964 -
Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)
|
||
| Completed |
NCT04597593 -
Association Between Genetic Variant Scores and DOACs (DARES2)
|
||
| Recruiting |
NCT05096338 -
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
|
||
| Recruiting |
NCT05078190 -
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
|
||
| Completed |
NCT02457039 -
Acupuncture Prevents Chemobrain in Breast Cancer Patients
|
N/A | |
| Completed |
NCT02779530 -
CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs
|
Phase 4 | |
| Recruiting |
NCT03047863 -
Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
|
N/A | |
| Recruiting |
NCT03051880 -
Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
|
N/A | |
| Completed |
NCT02482025 -
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
|
N/A | |
| Not yet recruiting |
NCT03147157 -
The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation
|
N/A | |
| Recruiting |
NCT03156348 -
Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults
|
N/A | |
| Recruiting |
NCT03501108 -
Discontinuation of Long-term Medications in Older People Entering Nursing Home Care
|
N/A | |
| Recruiting |
NCT06427317 -
Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment
|
||
| Completed |
NCT03227653 -
Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV
|
||
| Completed |
NCT03177174 -
Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma
|
N/A | |
| Recruiting |
NCT04077281 -
Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly In Transitions
|
N/A | |
| Not yet recruiting |
NCT05247814 -
Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
|
||
| Recruiting |
NCT03938597 -
Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers
|
||
| Recruiting |
NCT06291688 -
Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability
|
N/A |